A series of lupanol derivatives were synthesized and evaluated for their inhibitory activities against three human esophageal squamous carcinoma cells lines, Eca-109, TE-1 and EC-9706. Among lupanol derivatives, seven were new compounds, and lupanol cinnamate analogues and , hydrazone analogues and presented high activities towards all the tested tumour cells, even higher activities than those of doxorubicine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14786419.2020.1844687 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!